Biotech · Private company · Ann Arbor, MI, US
Evoq Therapeutics, Inc.
Track this companyFree. Adds Evoq Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards5
- NanoDiscs for Immune Modulation in Celiac DiseaseFiscal year 2026 · $1MNIH RePORTER 5R44AI192013-02 · fetched Nov 12, 2026
- NanoDiscs for Immune Modulation in Celiac DiseaseFiscal year 2025 · $1.1MNIH RePORTER 1R44AI192013-01 · fetched Nov 12, 2026
- Novel immunotherapy against MOG antibody diseaseFiscal year 2025 · $988.9KNIH RePORTER 5R44TR005293-03 · fetched Nov 12, 2026
- New approach for immune modulation against T1DFiscal year 2024 · $756.5KNIH RePORTER 5R44DK135218-02 · fetched Nov 12, 2026
- Novel immunotherapy against MOG antibody diseaseFiscal year 2024 · $1MNIH RePORTER 9R44TR005293-02 · fetched Nov 12, 2026